| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 21, 2006
Revised on July 11, 2006
Accepted on July 14, 2006
From the Center for Molecular Medicine and Therapeutics (R.R.S., H.V., E.R.J., J.M.C., L.R.B., M.H.K., M.R.H.), University of British Columbia and CFRI, Vancouver, British Columbia, Canada; the Whitaker Cardiovascular Institute (A.C., V.I.Z.), Boston University School of Medicine, Boston, Mass; and INSERM/CNRS et Universite de La Mediterranee (G.C.), Marseille, France.
* To whom correspondence should be addressed. E-mail: mrh{at}cmmt.ubc.ca.
Mutations in ATP-binding cassette transporter A1 (ABCA1) cause Tangier disease and familial hypoalphalipoproteinemia, resulting in low to absent plasma high-density lipoprotein cholesterol levels. However, wide variations in clinical lipid phenotypes are observed in patients with mutations in ABCA1. We hypothesized that the various lipid phenotypes would be the direct result of discrete and differing effects of the mutations on ABCA1 function. To determine whether there is a correlation between the mutations and the resulting phenotypes, we generated in vitro 15 missense mutations that have been described in patients with Tangier disease and familial hypoalphalipoproteinemia. Using localization of ABCA1, its ability to induce cell surface binding of apolipoprotein A-I, and its ability to elicit efflux of cholesterol and phospholipids to apolipoprotein A-I we determined that the phenotypes of patients correlate with the severity and nature of defects in ABCA1 function.
This article has been cited by other articles:
![]() |
S. Larrede, C. M. Quinn, W. Jessup, E. Frisdal, M. Olivier, V. Hsieh, M.-J. Kim, M. Van Eck, P. Couvert, A. Carrie, et al. Stimulation of Cholesterol Efflux by LXR Agonists in Cholesterol-Loaded Human Macrophages Is ABCA1-Dependent but ABCG1-Independent Arterioscler Thromb Vasc Biol, November 1, 2009; 29(11): 1930 - 1936. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rashid, M. Marcil, I. Ruel, and J. Genest Identification of a novel human cellular HDL biosynthesis defect Eur. Heart J., September 2, 2009; 30(18): 2204 - 2212. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Singaraja, M. H. Kang, K. Vaid, S. S. Sanders, G. L. Vilas, P. Arstikaitis, J. Coutinho, R. C. Drisdel, A. E. D. El-Husseini, W. N. Green, et al. Palmitoylation of ATP-Binding Cassette Transporter A1 Is Essential for Its Trafficking and Function Circ. Res., July 17, 2009; 105(2): 138 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nagao, Y. Zhao, K. Takahashi, Y. Kimura, and K. Ueda Sodium taurocholate-dependent lipid efflux by ABCA1: effects of W590S mutation on lipid translocation and apolipoprotein A-I dissociation J. Lipid Res., June 1, 2009; 50(6): 1165 - 1172. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hozoji, Y. Kimura, N. Kioka, and K. Ueda Formation of Two Intramolecular Disulfide Bonds Is Necessary for ApoA-I-dependent Cholesterol Efflux Mediated by ABCA1 J. Biol. Chem., April 24, 2009; 284(17): 11293 - 11300. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Vaughan, C. Tang, and J. F. Oram ABCA1 mutants reveal an interdependency between lipid export function, apoA-I binding activity, and Janus kinase 2 activation J. Lipid Res., February 1, 2009; 50(2): 285 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Brunham, J. J. P. Kastelein, and M. R. Hayden ABCA1 Gene Mutations, HDL Cholesterol Levels, and Risk of Ischemic Heart Disease JAMA, November 5, 2008; 300(17): 1997 - 1998. [Full Text] [PDF] |
||||
![]() |
J. F. Oram and A. M. Vaughan ATP-Binding Cassette Cholesterol Transporters and Cardiovascular Disease Circ. Res., November 10, 2006; 99(10): 1031 - 1043. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |